Session » Osteoporosis and Metabolic Bone Disease – Basic and Clinical Science Poster

Date: Sunday, November 13, 2022

Time: 1:00PM-3:00PM

Meeting: ACR Convergence 2022

1:00PM-3:00PM: Abstract Number: 1316

A Cluster of Paget Disease of the Bone in Black or African American Patients in a Veteran Population

1:00PM-3:00PM: Abstract Number: 1315

Building Stronger Bones: Optimizing Osteoporosis Screening at a Primary Care Clinic

1:00PM-3:00PM: Abstract Number: 1305

Characterizing Bone Microarchitecture with MRI in Patients with Systemic Lupus Erythematosus

1:00PM-3:00PM: Abstract Number: 1312

Cost-Effectiveness of Sequential Treatment with Abaloparatide Followed by Alendronate in US Men at High Risk of Fracture

1:00PM-3:00PM: Abstract Number: 1328

CT Evaluation of Bone Fragility 2 Years After Bariatric Surgery in Patients with Obesity: An Observational Study

1:00PM-3:00PM: Abstract Number: 1307

Effect of Romosozumab in Postmenopausal Women with Knee Osteoarthritis: Results from the FRAME Clinical Trial

1:00PM-3:00PM: Abstract Number: 1309

Evaluation of Preference and Efficacy in the Treatment of Glucocorticoid-induced Osteoporosis in Patients with Autoimmune Diseases Receiving Zoledronic Acid

1:00PM-3:00PM: Abstract Number: 1322

Follow up of Incidentally Noted Vertebral Compression Fractures

1:00PM-3:00PM: Abstract Number: 1304

Glucocorticoids Affect Bone Mass and Strength by Inhibiting Osteoprogenitor Cell Maturation

1:00PM-3:00PM: Abstract Number: 1327

Immune Cell Subsets and Risk of Incident Hip Fracture in Older Adults: The Cardiovascular Health Study

1:00PM-3:00PM: Abstract Number: 1326

Impact of COVID-19 Severity on Bone Mineral Density, Sarcopenia and Physical Performance Among Older Adults Following Hospitalization: A Pilot Study

1:00PM-3:00PM: Abstract Number: 1330

Impact of COVID-19 Severity on Physical Function, Mobility, Falls and Fractures Among Older Patients After Hospitalization: A Longitudinal Study

1:00PM-3:00PM: Abstract Number: 1306

Improving Osteoporosis Screening in Individuals of Color

1:00PM-3:00PM: Abstract Number: 1310

Is the Trabecular Bone Score (TBS) a Useful Tool in Patients with Diffuse Idiopathic Skeletal Hyperostosis (DISH)?

1:00PM-3:00PM: Abstract Number: 1318

Low-Dose Prednisolone (≤5 Mg/d) Is Not Associated with Deleterious Effects on Bone Mineral Density: Baseline Findings in a Cohort of Rheumatic Disease Patients with Prior Glucocorticoid Exposure

1:00PM-3:00PM: Abstract Number: 1320

Performance of FRAX® Brazil and NOGG Methodology with and Without Bone Mineral Density upon Predicting Fractures on a Community-Dwelling Elderly Population with High Incidence of Osteoporotic Fractures: The São Paulo Ageing and Health (SPAH) Study

1:00PM-3:00PM: Abstract Number: 1308

Prevalence and Therapeutic Practices of Osteoporosis in Sarcoidosis in the United States: A Nationwide Registry Study

1:00PM-3:00PM: Abstract Number: 1329

Prevalence of Bone Fragility on DXA and CT in Patients with Obesity

1:00PM-3:00PM: Abstract Number: 1319

Prognostic Utility of Metacarpal Bone Mineral Density Measurement in Patients with Recent-onset Arthritis by Assessment of Radiographic Progression at 2-year Follow Up

1:00PM-3:00PM: Abstract Number: 1314

Response Rates for Lumbar Spine, Total Hip, and Femoral Neck Bone Mineral Density with Abaloparatide in Men: Results from the ATOM Study

1:00PM-3:00PM: Abstract Number: 1331

Risk Factors for Osteoporotic Fracture in Women with Established Long-Term Rheumatoid Arthritis

1:00PM-3:00PM: Abstract Number: 1323

Secondary Prevention of Vertebral Fractures Sustained Efficacy over Time

1:00PM-3:00PM: Abstract Number: 1321

Systemic Inflammatory-based Scores and Bone Turnover Ratio as Novel Diagnostic Tools for Chronic Nonbacterial Osteomyelitis (CNO) of the Sternocostoclavicular Region in Adults

1:00PM-3:00PM: Abstract Number: 1317

The Epidemiology of Old versus Young Males Referred for BMD Assessment

1:00PM-3:00PM: Abstract Number: 1325

The Risks of Osteoporotic Fracture After Lung Transplant: A Retrospective Cohort Study at an International Transplant Center

1:00PM-3:00PM: Abstract Number: 1313

The Role of Tryptophan and Its Metabolites in Risk for Incident Hip Fractures and Frailty: The Cardiovascular Health Study

1:00PM-3:00PM: Abstract Number: 1324

Treatment Patterns in Women with Post-Menopausal Osteoporosis Using Abaloparatide: A Real-world Observational Study

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].